Phase II neoadjuvant pyrotinib combined with epirubicin and cyclophosphamide followed by docetaxel in HER2-low-expressing and HR-positive early or locally advanced breast cancer (PILHLE-001): A single-arm trial.
Cyclophosphamide;Docetaxel;Epirubicin;Pyrotinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase II neoadjuvant pyrotinib combined with epirubicin and cyclophosphamide followed by docetaxel in HER2-low-expressing and HR-positive early or locally advanced breast cancer (PILHLE-001): A single-arm trial. ### Output: Cyclophosphamide;Docetaxel;Epirubicin;Pyrotinib